Quizartinib
Generic name: quizartinib [ kwiz-AR-ti-nib ]
Brand name: Vanflyta
Dosage form: oral tablet (17.7 mg; 26.5 mg)
Drug class: Multikinase inhibitors
What is quizartinib?
Quizartinib is used in adults alone or in combination with other cancer treatments to treat acute myeloid leukemia.
Quizartinib is available only from a certified pharmacy under a special program. You must be registered in the program and understand the risks and benefits of quizartinib.
Quizartinib may also be used for purposes not listed in this medication guide.
Quizartinib side effects
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Quizartinib can cause a serious heart problem, especially if you use certain medicines at the same time. Call your doctor right away if you have irregular heartbeat, a light-headed feeling, like you might pass out, or have diarrhea or vomiting.
Your dose may be decreased and your treatment may be delayed or permanently discontinued if you have certain side effects.
Common side effects of quizartinib may include:
-
nausea, vomiting, stomach pain, upset stomach, diarrhea, loss of appetite;
-
eye irritation;
-
nosebleeds;
-
cold symptoms such as stuffy nose, sneezing, sore throat;
-
herpes infection;
-
trouble sleeping;
-
low levels of platelets in your blood;
-
an electrolyte imbalance (such as low blood levels of potassium or magnesium);
-
changes in liver function tests;
-
an abnormal electrocardiogram or ECG (sometimes called an EKG); or
-
low blood cell counts--fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Related/similar drugs
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Xospata
Xospata (gilteritinib) is used to treat acute myeloid leukemia (AML) with a FLT3 mutation. Xospata ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Revuforj
Revuforj is used to treat acute leukemia with a lysine methyltransferase 2A gene translocation ...
Ivosidenib
Ivosidenib systemic is used for acute myeloid leukemia, biliary tract tumor, myelodysplastic syndrome
Revumenib
Revumenib systemic is used for acute lymphoblastic leukemia, acute myeloid leukemia, leukemia
Daunorubicin
Daunorubicin systemic is used for acute lymphocytic leukemia, acute myeloid leukemia, acute ...
Azacitidine
Azacitidine systemic is used for acute myeloid leukemia, myelodysplastic syndrome
Cytarabine
Cytarabine systemic is used for acute myeloid leukemia, acute nonlymphocytic leukemia, chronic ...
Warnings
Quizartinib can cause a serious heart problem, especially if you use certain medicines at the same time. Call your doctor right away if you have irregular heartbeat, a light-headed feeling, like you might pass out, or have diarrhea or vomiting.
Quizartinib is available only from a certified pharmacy under a special program. You must be registered in the program and understand the risks and benefits of quizartinib.
Before taking this medicine
You should not use quizartinib if you are allergic to it, or if you have:
-
very low magnesium level;
-
very low potassium level;
-
long QT syndrome; or
-
history of ventricular arrhythmias or torsades de pointes.
Tell your doctor if you have or have ever had:
-
heart problems; or
-
low blood levels of potassium or magnesium.
Quizartinib can harm an unborn baby if the mother or the father is using this medicine.
-
If you are a woman, you will need a pregnancy test to make sure you are not pregnant. Use birth control while using this medicine and for at least 7 months after your last dose.
-
If you are a man, use birth control if your sex partner is able to get pregnant. Keep using birth control for at least 4 months after your last dose.
-
Tell your doctor right away if a pregnancy occurs.
Pregnancy may be less likely to occur while the mother or the father is using this medicine. Both men and women should still use birth control to prevent pregnancy because the medicine can harm an unborn baby.
Do not breastfeed while using this medicine, and for at least one month after your last dose.
How should I take quizartinib?
Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.
Do not change your dose or stop taking the medicine without your doctor's advice.
Quizartinib is usually taken once per day with or without food at the same time each day.
If you vomit shortly after taking quizartinib, do not take another dose. Take your next dose as scheduled.
Swallow the tablet whole and do not crush, chew, or break it.
You may need medical tests before and during your treatment with quizartinib to check your heart function using an electrocardiograph or ECG (sometimes called an EKG).
Your blood will be tested before and during treatment with quizartinib.
Store at room temperature away from moisture and heat.
What happens if I miss a dose?
Take the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while taking quizartinib?
Avoid taking an herbal supplement containing St. John's wort.
What other drugs will affect quizartinib?
Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase side effects or make the medicines less effective.
More about quizartinib
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2025 Cerner Multum, Inc. Version: 1.01.